Old Web
English
Sign In
Acemap
>
Paper
>
Integrated Safety Analysis of Tagraxofusp, a CD123-Directed Targeted Therapy, in Patients with Hematologic Malignancies
Integrated Safety Analysis of Tagraxofusp, a CD123-Directed Targeted Therapy, in Patients with Hematologic Malignancies
2021
Naveen Pemmaraju
Hagop M. Kantarjian
Kendra Sweet
Eunice S. Wang
Andrew A. Lane
Haris Ali
Anthony S. Stein
Abdulraheem Yacoub
David A. Rizzieri
Sumithira Vasu
Vikas Gupta
Sangmin Lee
Gary J. Schiller
James M. Foran
Minakshi S. Taparia
Todd L. Rosenblat
Roland B. Walter
Debra Sieminski
Madhu Anant
Mrinal M Patnaik
Tariq I. Mughal
Marina Konopleva
Keywords:
Oncology
Internal medicine
Interleukin-3 receptor
Targeted therapy
Medicine
in patient
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]